Page last updated: 2024-10-20

quinolinic acid and Primary Hyperparathyroidism

quinolinic acid has been researched along with Primary Hyperparathyroidism in 1 studies

Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.
quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verheyen, N1
Meinitzer, A1
Grübler, MR1
Ablasser, K1
Kolesnik, E1
Fahrleitner-Pammer, A1
Belyavskiy, E1
Trummer, C1
Schwetz, V1
Pieske-Kraigher, E1
Voelkl, J1
Alesutan, I1
Catena, C1
Sechi, LA1
Brussee, H1
Lewinski, DV1
März, W1
Pieske, B1
Pilz, S1
Tomaschitz, A1

Trials

1 trial available for quinolinic acid and Primary Hyperparathyroidism

ArticleYear
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
    Clinical chemistry and laboratory medicine, 2017, Jun-27, Volume: 55, Issue:7

    Topics: Aged; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Echocardiography; Female; Humans; Hyp

2017